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Abstract 
With increasing life expectancies and the desire to maintain active life-styles well into old age, the 
impact of the debilitating disease osteoarthritis (OA) and its burden on health care services is 
mounting. Emerging regenerative therapies could deliver significant advances in the effective 
treatment of OA but rely upon the ability to identify the initial signs of tissue damage and will also 
benefit from quantitative assessment of tissue repair in vivo. Continued development in the field of 
quantitative magnetic resonance imaging (MRI) in recent years has seen the emergence of 
techniques able to probe the earliest biochemical changes linked with the onset of OA. Quantitative 
MRI measurements including T1, T2 and T1ρ relaxometry, diffusion weighted imaging and magnetisation 
transfer have been studied and linked to the macromolecular structure of cartilage. Delayed 
gadolinium-enhanced MRI of cartilage (dGEMRIC), sodium MRI and glycosaminoglycan chemical 
exchange saturation transfer (gagCEST) techniques are sensitive to depletion of cartilage 
glycosaminoglycans (GAG) and may allow detection of the earliest stages of OA. We review these 
current and emerging techniques for the diagnosis of early OA and evaluate the progress that has 
been made towards their implementation in the clinic and identify future challenges in the field.  
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Introduction 
The treatment of the degenerative joint disease osteoarthritis (OA) remains problematic. For 
advanced end stage “whole organ” disease the only viable treatment option is joint replacement 
where feasible. For earlier stage OA, disease progression is unpredictable and often slow which 
makes it very difficult to evaluate agents that have possible disease modifying properties. Although 
the OA disease process may commence within any joint structure including ligaments, bone, 
meniscus or articular cartilage, the advancement of disease is inevitably associated with progressive 
cartilage attrition and inexorable functional deterioration. The non-invasive assessment of tissue 
damage (at a stage in the disease process where tissue damage is potentially reversible) and the 
ability to monitor its repair during and following treatment is central to future development of novel 
therapies aimed at arresting or reversing cartilage destruction. 
The purpose of this review is to evaluate current and emerging quantitative magnetic resonance (MR) 
protocols for assessment of cartilage in order to identify the open challenges that will drive further 
development in the field. Of specific interest are the methods that can detect the initial stages of 
cartilage degradation and also those that allow the biomechanical properties of cartilage to be 
studied. Such techniques might be important aids for early diagnosis of arthritic diseases and also in 
assessing the progress of regenerative and reparative therapies for OA in vivo.[1, 2] An ideal scenario 
would be the development of high resolution whole body magnetic resonance imaging methods that 
could provide functional information about the state of cartilage at multiple sites, in a timely and cost 
effective fashion, without resort to exogenous contrast agents. This is particularly challenging for the 
assessment of cartilage as high spatial resolution is required. We will discuss what degree of 
progress has been made towards that lofty goal where MRI biomarkers could be used to reliably 
identify and characterise early cartilage damage or sites at risk of cartilage loss.  
 
Cartilage composition 
The purpose of articular cartilage is to provide a wear-resistant, low friction, force distributing material 
between the comparatively rigid subchondral bone surfaces in diarthrodial joints. At a macromolecular 
level cartilage consists of an extracellular matrix (ECM) made up of a network of collagen fibrils and 
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proteoglycan (PG) molecules.[3] PG itself consists of a protein core with covalently attached 
negatively-charged glycosaminoglycans (GAGs). This macromolecular matrix accounts for around 20-
30% of the tissue weight. The rest is made up of fluid, containing mobile charge-balancing cationic 
species[4] (Figure 1a). The mechanisms by which the electrolytic fluid, collagen network and 
proteoglycan interact with each other confer articular cartilage its biomechanical properties and allow 
it to withstand and distribute the various forces experienced during joint articulation. Early 
osteoarthritic changes in articular cartilage occur in the ECM with loss of proteoglycan accompanied 
by heightened water content.[5] The loss of proteoglycan and, therefore, negative fixed charge 
density (FCD) results in increased water mobility in the cartilage matrix and a diminished capacity to 
cope with mechanical loading (Figure 1b). This in turn exposes the cartilage to further degradation. 
Thus there is a great deal of interest and merit in searching for diagnostic techniques that are 
sensitive to the earliest micro-scale biochemical changes associated with cartilage degradation and 
OA.[2] 
  
MRI of cartilage 
Since its introduction into clinical practice in the 1980s, MRI has become a powerful and capable 
diagnostic tool, and excels in its ability to acquire images with a high degree of soft-tissue contrast 
non-invasively and in 3-D.[6] Image contrast can be varied through choice of imaging parameters in 
order to emphasise different types of tissue. In conventional MRI sequences contrast is typically 
afforded by making the signal intensity of each pixel in the image partially dependent upon – or 
“weighted” by – either the T1 or T2 relaxation time of the hydrogen nuclei contained within that pixel. 
The T1 and T2 relaxation times of nuclei are determined by their physiochemical environment and can 
thus vary between different tissue types. MR sequences in which both T1 and T2 weighting are 
minimized are said to be proton density weighted, meaning the signal is determined almost solely by 
the local concentration of hydrogen nuclei. 
 
MRI is already widely used in the clinic for assessment of articular cartilage and gross joint 
morphology as well as the identification of other arthritic features including osteophytes, bone marrow 
oedema and meniscal and ligament tears.[7-10] The need to differentiate between articular cartilage 
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and a range of surrounding tissue types (bone, muscle, fat, synovial fluid etc.), has meant that a 
number of MR pulse sequences are used in a typical clinical assessment (Figure 2). The design of the 
National Institute of Health Osteoarthritis Initiative knee MRI protocol[7] serves to highlight the variety 
of sequences implemented; the protocol includes sequences with T1-weighted, T2-weighted and 
intermediate-weighted contrasts utilising both spin-echo (SE) and gradient recalled echo (GRE) 
methods. Imaging planes are prescribed in sagittal and coronal directions and 2-D and 3-D images 
are acquired with the latter allowing for images to be reconstructed in multiple planes. The entire 
protocol is designed to be performed in a relatively short timeframe with respect to patient comfort 
and allows quantitative and semi-quantitative assessments of a multitude of structural features and 
pathologies within the knee joint. 
 
Advances in the design of superconducting magnets have facilitated scanners and spectrometers with 
stronger static magnetic fields, allowing for imaging with a combination of increased signal-to-noise 
ratio (SNR), higher spatial resolution and accelerated acquisition time. Experimental narrow-bore 
magnets with field strengths of 9.4 T and 11.7 T are common, whilst whole body scanners with 3.0 T 
fields are becoming more prevalent in clinical settings.[11] Similarly, progress in imaging pulse 
sequence design and development of more sensitive and sophisticated radiofrequency (RF) coils has 
led to MRI techniques that are able to directly assess the microscopic structure and biochemical 
composition of musculoskeletal tissues in addition to imaging macroscopic structural and anatomical 
detail. The capacity to determine microscopic structure and composition is a key factor for diagnosis 
of OA as macroscopic degenerative changes (e.g. cartilage defects or joint space narrowing) are 
usually absent in the early stages of the disease.[12] Moreover, gross structural changes with joint 
malalignment may not be amenable to putative therapies.[13] The remainder of this review will focus 
on emergent quantitative MRI techniques that allow this microscopic assessment of articular cartilage. 
 
T1 relaxation  
Whereas signal intensity in the weighted imaging sequences briefly introduced above is a function of 
both the concentration (spin-density) and one or more intrinsic properties (e.g. T1, T2) of the imaged 
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nuclei, the aim with quantitative MRI techniques is to survey or “map” the absolute value of these 
intrinsic properties on a pixel-by-pixel basis (Figure 3). 
The spin-lattice or T1 relaxation time governs the rate at which nuclei return energy to their 
surroundings (the “lattice”) following excitation.[14] The factors affecting native T1 relaxation times in 
articular cartilage are not well understood though it has been reported that native T1 values are 
sensitive to the macromolecular structure of the cartilage matrix.[15] The exact nature of this 
relationship is unclear, but is believed to relate more to the PG content of the tissue than the collagen 
architecture.[16] A systematic survey of native T1 in different cartilage compartments of healthy 
human volunteers was undertaken by Wiener et al.[17] In this study, T1 values were shown to 
decrease from the superficial cartilage layers to the deep layer, consistent with the dependence of 
native T1 values upon the macromolecular construction of cartilage. 
 
Contrast enhanced T1 - dGEMRIC 
The studies described in the previous section are primarily concerned with the native T1 relaxation 
time of cartilage. An area which has received considerably more attention is the mapping of the T1 
relaxation time of cartilage in the presence of the gadolinium contrast agent gadolinium 
diethylenetriamine pentaacetic acid ([Gd(DTPA)
2-
]). This forms the basis of the delayed gadolinium-
enhanced MRI of cartilage (dGEMRIC) technique.[18] The distribution of the negatively-charged 
contrast agent is inversely proportional to the cartilage fixed charge density due to the presence of 
negatively-charged GAG side chains on proteoglycan (Figure 4). Areas of cartilage with depleted 
GAG concentration therefore accumulate more contrast agent. The highly paramagnetic gadolinium 
ions promote relaxation processes, leading to a localised reduction in the T1 relaxation time. 
dGEMRIC can, therefore, be used to determine the spatial variation of tissue GAG concentration and 
is a technique that shows promise as a specific measure of early degradation in the cartilage ECM 
associated with OA.[19] In a clinical setting, there is support for the efficacy of the technique for 
detecting pre-radiographic signs of OA in the knee[20] and hip joints[21]. 
A number of practical considerations relating to the in vivo implementation of the dGEMRIC technique 
have been investigated and addressed by Burstein et al.[22] The relationship between the contrast 
enhanced T1 and GAG concentration is subject to effective penetration of the contrast agent into the 
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cartilage, which may be affected by a patient’s body mass index (BMI) and/or ratio of fat to lean 
tissue. They recommend intravenous injection of a double dose (0.2 mM kg
-1
) of Gd(DTPA)
2-
, followed 
by a 10 minute period of exercising the joint to aid penetration of the contrast agent into the cartilage. 
Maximum contrast is achieved 2 hours post injection for the knee joint. A separate study reports that 
complete equilibration of [Gd(DTPA)
2-
] throughout the entire thickness of the cartilage may take as 
long as 12 hours.[23] Additionally, the direction and type of loading experienced by the joint during the 
exercise period may affect the distribution of the contrast agent.[24] 
A further consideration for dGEMRIC is whether both pre- and post-contrast T1 values are required to 
accurately evaluate variations in cartilage GAG content.[1, 25-27] Where only the post-contrast T1 is 
used to report the so called dGEMRIC index, the assumption has been made that the pre-contrast 
value of T1 ( ) is relatively constant and that the post-contrast value of T1 is sufficiently small 
compared to . The current consensus is that the post-contrast T1 gives a sufficiently accurate 
measure of GAG concentration and the time-consuming measurement of pre-contrast T1 is not 
necessary.[28] 
Apart from these concerns, there is a desire to implement faster T1 mapping protocols with higher 
resolution and 3-D joint coverage. This would be beneficial for both in vitro and in vivo studies alike 
because quantitative T1 mapping techniques are typically time consuming. This is increasingly 
relevant at higher field strengths where T1 relaxation times increase, resulting in even longer scan 
times.[29] Accurate 3-D T1 mapping protocols have been implemented on 1.5 T and 3.0 T platforms 
using 3-D inversion recovery spoiled gradient echo,[29] 3-D Look-Locker[30] and 3-D fast two-angle 
T1 mapping[31] methods. 
 
T2 relaxation  
T2 relaxation concerns the loss of phase coherence between nuclei following excitation by an RF 
pulse. Immediately after the excitation, nuclei have phase coherence resulting in a detectable net 
magnetisation vector.[14] As T2 relaxation occurs, this phase coherence is lost and the observable 
NMR signal decays exponentially with time. In cartilage, the restricted motion of water molecules 
imposed by the macromolecular structure of the ECM promotes relaxation, resulting in shorter T2 
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relaxation times.[1] T2 relaxation times are therefore dependent on both the water content and 
condition of the surrounding macromolecular structure.[32] Increased hydration of cartilage and 
breakdown of cartilage collagen are both early indicators of osteoarthritic disease[5] and as such 
there is considerable interest in the potential for T2 to be used as a predictor of early OA.[33] Early 
work in this area was conducted by Dardzinski et al in a study of 7 asymptomatic adults.[34] Cartilage 
T2 relaxation times were shown to vary across the thickness of the cartilage in a manner consistent 
with the known spatial distribution of cartilage water and proteoglycan content. The erosion of the 
cartilage ECM and increased tissue water content associated with degraded tissue is generally linked 
with higher T2 values. Dunn et al have reported on the correlation between increased T2
 
values and 
severity of OA in a study of 55 patients.[35]. Subjects with mild and severe OA had significantly higher 
cartilage T2 values than healthy subjects. A study of the Osteoarthritis Initiative patient cohort has also 
shown a link between heightened T2 values of patellar cartilage and knee abnormalities.[36] It has, 
however, been suggested[1] that explicit interpretation of changes in T2 should be made with care, 
due to the number of competing biological and mechanical effects that influence T2. 
The effect of the collagenous architecture on T2 relaxation times is evident in the zonal variation of T2 
values in the deepest cartilage layers adjacent to the bone and in the tangential zone cartilage at the 
articular surface. In the deep and tangential layers of articular cartilage where the orientation of 
collagen fibrils is anisotropic, T2 values show a dependence on the alignment of the cartilage with the 
static magnetic (B0) field.[37, 38] This dependence is not observed in the intermediate cartilage layer 
where there is a random distribution of collagen fibril orientations. The effect on T2 values arises due 
to the so called magic angle effect[14] whereby the dipole-dipole interactions between nuclei that 
promote relaxation are minimised when the angle between the inter-nuclear vector and the static 
magnetic field is 54.7°.  While it is apparent that T2 values in cartilage are strongly influenced by the 
collagen architecture, with a study by Nissi et al[39] suggesting 60% of the variation in T2 values can 
be rationalised by changes in the collagen fibril orientation, the remaining 40% is then determined by 
other factors including water content[40] and concentration of other macromolecules.[41] This 
reiterates the need for care in interpreting variation in T2 relaxation times. 
A further consideration for evaluation of cartilage T2 relaxation times is the need for MR pulse 
sequences that are able to probe tissues with short (< 10 ms) T2 values, including calcified cartilage 
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and fibrocartilage.[42] Ultrashort echo time (UTE) MRI sequences are sensitive to these very short 
relaxation times and allow quantitative assessment of the highly organised collagen network 
particularly in the deep and calcified cartilage zones.[43] 
 
T1ρ relaxation  
The spin-lattice relaxation time in the rotating frame (T1ρ) is sensitive to low frequency exchange 
interactions between water molecules and the large, slow tumbling macromolecules that constitute 
the cartilage ECM.[33] T1ρ measurements are performed by using a preparatory spin-locking pulse 
that attenuates T2 relaxation and causes the magnetisation to evolve according to the T1ρ relaxation 
time of the nuclei.[44] Following the spin-locked preparation of the magnetisation, spatial encoding of 
the NMR signal can be achieved using standard sequences, including spin echo[45] and gradient 
echo.[46, 47] Variation of the pulse duration allows points on the T1ρ decay curve to be sampled and 
the T1ρ relaxation time determined.  
T1ρ measurements have been shown to be sensitive to changes in proteoglycan content in 
enzymatically degraded bovine cartilage[45, 48] indicating the potential for T1ρ to be used as a 
biomarker for the early stages of OA. A more recent study has examined the ability of quantitative T1ρ 
measurements to identify cartilage degeneration as validated by arthroscopic investigation, with T1ρ 
showing the potential to identify cartilage with softening and swelling corresponding to a grade I 
classification on the Outerbridge scale used for visual assessment of chondral lesions.[49] Evaluation 
of cartilage repair in patients undergoing microfracture and mosaicplasty surgical procedures has also 
been performed[50] using T1ρ. 
There are several studies comparing the relative sensitivities of quantitative T1ρ and T2 measurements 
to the earliest degenerative changes in the cartilage ECM.[51, 52] The consensus is that T1ρ may be 
more sensitive to the initial changes in the cartilage ECM associated with PG depletion whereas T2 is 
only sensitive to later changes in the collagen network. Furthermore, the relative change in T1ρ values 
in healthy tissue versus degenerative tissue is larger than for T2, offering an improvement in dynamic 
range for detecting early OA pathology.[53] It has also been shown that T1ρ values appear to be 
unaffected by the laminar structure of cartilage.[54]  
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There are still conflicting opinions on the specificity of T1ρ measurements for measuring PG content[1, 
44, 55] because T1ρ may be at least partially susceptible to the same competing factors that limit the 
specificity of T2 measurements, such as tissue collagen content and hydration. The availability of 
standard clinical T1ρ pulse sequences can also be problematic.[1] Additionally, the long duration of the 
spin-locking pulse means that large amounts of RF energy are transmitted to the subject during the 
pulse sequence, and this must be controlled within prescribed limits for safe use on patients.[44] This 
is particularly pertinent at higher field strengths as the RF energy transmitted for any discrete 
excitation increases with the square of the field strength.[56] 
 
Relationship between mechanical properties of cartilage and quantitative MRI 
Due to the sensitivity of certain MR techniques to the macromolecular structure and content of 
articular cartilage, there is a related interest in the prediction of the mechanical properties of cartilage 
using these non-invasive MRI methods. Continued development of such methods could have a 
significant impact on the ability to inform biotribological studies of articular cartilage wear and 
degeneration.[57, 58] 
Nissi et al have attempted to determine the relationship between the mechanical properties of human, 
bovine and porcine patellar cartilage and MR parameters of the tissue.[15] Native T1 and T2 values 
and the gadolinium-enhanced T1 (dGEMRIC) were measured along with the Young’s modulus and 
dynamic modulus of the samples. Lower native T1 relaxation times were found in tissue with high 
stiffness possibly reflecting the reduced water content and high concentration of collagen and PG in 
such areas. The relationship between stiffness and T2 values was less clear. Differences in the 
laminar structure of the cartilage samples relating to the varying stages of maturity presented a 
complex relationship between stiffness and bulk T2 values. However, a significant correlation was 
observed when data for human, bovine and porcine cartilage were pooled together. Somewhat 
surprisingly, given the relationship between dGEMRIC and PG content, the study did not find any 
significant correlation between the measured mechanical properties and contrast enhanced T1 values. 
This was attributed to the dominating effect of the collagen architecture to which dGEMRIC is 
insensitive. Juras et al[59], have since reported a high correlation between contrast enhanced T1 
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values and the instantaneous and equilibrium modulus values of human cartilage explants. This study 
also reiterated the difficulty in correlating T2 with stiffness values. 
The sensitivity of T1ρ measurements to proteoglycan content has been exploited by Wheaton et al[60] 
in an attempt to measure mechanical properties of cartilage using MRI. In this work, changes in the 
T1ρ relaxation time were shown to correlate with both the proteoglycan content, as determined by 
spectrophotometric assay, and the compressive modulus and hydraulic permeability of bovine 
cartilage samples. 
More recent work by the group from the University of Kuopio has involved the development of a finite 
element model (FEM)[16, 61] to infer mechanical properties of cartilage from MR parameters and 
other complementary methods e.g. infrared imaging and polarised light microscopy. This work 
concludes that a FEM can infer mechanical properties of cartilage, given the depth-dependent 
collagen content, the PG and water content and collagen architecture. MR techniques can determine 
water and PG content and collagen architecture, but not the collagen content.  
 
Sodium-MRI 
Sodium-MRI offers an alternative method to dGEMRIC for the measurement of cartilage FCD. 
Negative FCD in the cartilage ECM is charge balanced by the presence of positively-charged sodium 
ions (Figure 5). Thus, determination of the concentration of sodium within the tissue allows the 
negative FCD, and hence GAG concentration, to be quantified.[44] The first evidence of the suitability 
of sodium MRI for this type of measurement was presented as far back as 1988.[62] Gradient echo 
MR images of various tissues, including cartilage, were obtained at 1.9T with moderate acquisition 
times (2-30 minutes). As with the dGEMRIC method, measurement of FCD using sodium MRI is 
highly specific to the GAG concentration but importantly, does not require the use of a contrast agent; 
intravenous administration of contrast agent is invasive and potentially uncomfortable for the patient, 
prolongs the examination time and has been associated with increased risk of nephrogenic fibrosing 
dermopathy.[63] Several reports[64-66] have since demonstrated the specificity of the technique for 
detecting cartilage degradation through small changes in the FCD, along with improvements in image 
quality and speed of image acquisition. Clinical studies of cartilage using sodium-MRI remain 
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comparatively rare, hampered by the technical difficulties of obtaining sufficient signal-to-noise in a 
clinically relevant time frame. 
The major challenges involved in sodium MRI arise due to the inherently lower concentration of 
23
Na 
nuclei in the cartilage ECM and a smaller gyromagnetic ratio compared to the 
1
H nucleus. The T1 and 
T2 relaxation times of sodium are also comparably short. Combined, these factors have an impact on 
the achievable signal-to-noise ratio and image resolution using the technique.[44] Signal loss due to 
rapid T2 relaxation can be offset by the use of ultrashort echo time sequences.[67] Indeed, a precise 
measurement of sodium concentration using sodium MRI necessitates the use of UTE or similar 
sequences due to the rapid T2 relaxation rate of the sodium nucleus.[44] SNR enhancement is also 
facilitated through the use of radial k-space acquisition trajectories,[68, 69] where the NMR signal is 
acquired immediately after excitation from the centre of k-space and therefore does not undergo 
decay during the phase-encoding steps required in a conventional Cartesian k-space trajectory. 
 
Magnetisation transfer 
In a conventional MR imaging sequence, it is the hydrogen nuclei of unbound bulk water molecules 
that contribute to the observed signal. In a magnetisation transfer sequence, a preparatory saturation 
pulse is applied prior to the main MR sequence, which excites the broad signal of less mobile 
macromolecule-bound water molecules (Figure 6a). Exchange between the two water pools results in 
an attenuation of the bulk water signal, the extent of which depends on the kinetics of the exchange 
process and the volume of the bound water pool.[70] Magnetisation transfer contrast (MTC) is 
therefore used to highlight interactions between the bulk water and macromolecules (bound water). 
The extent of magnetisation transfer is often expressed as the magnetisation transfer ratio (MTR) 
which is simply the ratio of signal intensities observed with and without the application of the 
preparatory saturation pulse. An alternative metric is the rate constant for exchange of water between 
the two pools.[71] 
For cartilage imaging the important magnetisation transfer interaction is between bulk water and water 
bound to the collagen fibres present in the cartilage ECM although there is also a contribution from 
proteoglycan.[72-75] Regatte et al[72] have investigated the depth-dependence of MTR values in 
bovine cartilage samples and observed higher MTRs in the deep cartilage zone. This was attributed 
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to the depth-wise variation in cartilage collagen content as well as variations in the radial orientation of 
collagen fibrils and variations in the bound water fraction throughout the thickness of the cartilage. 
Yao et al[76] have reported on the insensitivity of MTR measurements to early degenerative changes 
in cartilage, also suggesting that the dependence of the MTR on multiple factors makes variation in 
MTRs difficult to interpret. 
A recent development of the magnetisation transfer principle is the chemical exchange-dependent 
saturation transfer (CEST) technique.[77] Exchangeable protons of a solute are selectively excited 
and chemical exchange of these protons with water protons results in a detectable decrease in the 
magnetisation of the bulk water pool[78] (Figure 6c). By saturating hydroxyl residues of 
glycosaminoglycan (Figure 7), the CEST effect can be exploited to directly measure GAG content in 
vivo.[79] In this study by Ling et al, the gagCEST technique was implemented in vivo on a 3 T clinical 
scanner and was able to show the demarcation of a cartilage lesion in a human knee joint. Schmitt et 
al[80] have compared the gagCEST technique with sodium MRI in a study performed at 7 T on 
patients who had undergone cartilage repair surgery, with a high correlation observed between the 
two techniques. 
 
Diffusion MRI 
Diffusion MRI techniques are sensitive to the restriction of motion of water molecules bound within a 
macromolecular environment. Diffusion sensitive MRI methods use paired magnetic field gradient 
pulses to probe the motion of nuclei in the direction of the applied magnetic field gradient.[81] The two 
pulses are of equal duration and amplitude and are separated by a time delay (D). The net effect of 
the paired gradient pulses is to dephase magnetisation from nuclei which have undergone diffusion 
during the time delay resulting in a measurable signal attenuation. The measured signal (S), is related 
to the diffusion coefficient (D) of the nuclei by the Stejskal-Tanner equation[82] 
  (1) 
where g is the gyromagnetic ratio of the diffusing nuclei, G and d are the amplitude and duration of the 
applied gradient pulses respectively and S0 is the measured signal intensity when G=0. Typically, a 
diffusion sensitive MRI sequence consists of a number of diffusion gradient pulses applied along 
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multiple axes as well as imaging gradients for spatial localisation of the signal. It then becomes 
convenient to summarise the combined influence of the gradients through calculation of the b-
factor.[83] The b-factor determines the overall diffusion-weighting of a sequence in the same way that 
the echo time characterises the degree of T2-weighting. Acquisition of images with multiple b–factors 
thus allows the diffusion coefficient to be mapped on a pixel-by-pixel basis.  
When measuring the diffusion coefficient of water molecules in physiological systems, there is 
significant interaction between the water molecules and their surrounding environment during the 
timescale of the experiment and the parameter measured is the apparent diffusion coefficient (ADC). 
Consequently, measuring the ADC of water molecules within the cartilage ECM can be used to infer 
cartilage tissue structure and architecture,[84, 85] with increased diffusivity linked to structural 
degradation of the ECM. The potential of diffusion weighted imaging (DWI) has been demonstrated as 
a method for assessing cartilage degeneration in vivo[86] and monitoring its repair following 
surgery.[8, 87] A recent longitudinal study by Friedrich et al[88] has shown the ability of DWI to 
differentiate between healthy and repaired cartilage at different time points after surgery of patients 
who underwent matrix-assisted autologous chondrocyte transplantation. The authors highlight the 
difficulty of obtaining precise measures of the diffusion values, and compare only the relative changes 
in diffusivity in this study. 
Whereas DWI can report the localised average diffusivity, diffusion tensor imaging (DTI) can be used 
to obtain the directionality of localised diffusion, revealing the orientation of collagen fibrils in the 
cartilage ECM.[89] DTI has been used to study the effects of compression on the cartilage collagen 
network,[90] and a recent study has reported on the use of ultra-high field (17.6 T) DTI to inform a 
finite element simulation of cartilage deformation.[91] At present though, DTI is unlikely to be 
applicable for in vivo assessment of cartilage due to the intensive data analysis required as well as 
lengthy acquisition times even at high field strengths. 
 
Imaging of related musculoskeletal tissues 
The focus so far has been on imaging methods for the assessment of articular cartilage. However, 
MRI has also been able to show the involvement of related joint structures in the early expression of 
OA.[92, 93] In this study, high resolution MRI of the hand was carried out using standard clinical 
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protocols on a 1.5 T scanner and compared to histological sections of cadaveric joints. Abnormalities 
in the collateral ligaments of the distal interphalangeal joint were observed adjacent to sites of bone 
oedema, bone erosion and new bone formation. In some cases ligament abnormalities were seen in 
joints without large scale loss of cartilage, showing that ligament abnormalities may precede 
degenerative changes in cartilage in some cases of OA. 
The structure of the enthesis organ (the complex arrangement of ligaments and tendons and their 
interfaces with bone) and its involvement in both inflammatory and degenerative arthritides is also of 
interest.[94, 95] The use of both conventional MR sequences and UTE sequences for visualisation of 
the enthesis has been studied,[42, 96] allowing the presence of fibrocartilage to be shown in the 
enthesis. Previously histological sectioning has been required to determine the presence of 
fibrocartilage. Imaging sequences utilising ultra-short echo times or UTE sequences are a relatively 
recent innovation in MRI.[97] Employing imaging sequences with echo times as short as 50 μs allows 
the signal components with very short T2 relaxation times to be observed,[98] which otherwise decay 
too rapidly to be observed with standard echo times ( > 5 ms). UTE sequences have also enabled 
magnetisation transfer contrast imaging of tissues with rapid signal decay; Springer et al[99] have 
measured MTRs in vitro in bovine cortical bone and in vivo in healthy human volunteers, 
demonstrating the feasibility of the technique for clinical applications.  
 
Key open questions 
There is currently significant interest in the identification of biomarkers that would allow the early 
detection of osteoarthritis.[2] There are a number of MR measurable parameters that have been 
shown to be sensitive to early biochemical changes, including depletion of GAG and collagen fibre 
breakdown. The question remains as to which of these parameters are best suited to fulfil the needs 
of clinicians in making an early diagnosis. For routine use in a clinical setting potential imaging 
techniques should be reliably performed in a relatively short time. Long scanning sessions are 
uncomfortable for patients and may result in poor quality images due to patient motion. If the ultimate 
goal of routine screening of patient groups at risk of developing OA is to be achieved, then completely 
non-invasive MR methods would be preferable; methods requiring intravenous administration of 
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contrast agents are not only invasive and associated with increased incidence of nephrogenic 
fibrosing dermopathy but also prolong the examination period, reducing their practicality. 
At present, MRI measures of cartilage composition in OA are predominantly used in a research 
setting to assess potential treatment strategies and to better understand the disease process. 
Ultimately, the wider clinical applicability of these techniques will depend on the development of new 
OA treatments e.g. drugs, physiotherapy regimes or minimally invasive surgical procedures. In this 
context, the ability to detect early cartilage changes (before the development of potentially irreversible 
structural abnormalities) and assess disease progression and response to treatment would be of 
potential clinical value. Another key issue for detecting early cartilage changes using MRI would be 
targeting of appropriate patient groups at risk of developing OA. Such screening may be based on a 
variety of predisposing factors including those associated with certain high risk occupations and 
sporting activities as well as previous injury.  
MRI methods that are sensitive to the GAG content of cartilage currently represent the most 
promising opportunities for early non-invasive assessment of cartilage degeneration. Both sodium 
imaging and dGEMRIC offer a highly specific method of GAG quantification through measurement of 
tissue fixed charge density. However, the dGEMRIC method requires the use of exogenous contrast 
agent making it subject to the disadvantages cited above. Sodium MRI is completely non-invasive but 
the method is technically demanding, requiring specialist RF coils, pulse sequences and high field 
strength magnets to obtain useful results. Development of the technique may be stimulated by the 
increasing presence of clinical 3T scanners but it may be that even higher field strengths are required. 
The specificity and non-invasiveness of the gagCEST technique would appear to make it a highly 
favourable technique with which to assess GAG content in vivo. The feasibility of the technique for in 
vivo studies has been demonstrated[79, 80] and the major challenge will be to develop robust CEST 
pulse sequences suitable for use in a clinical setting. 
The potential for T1ρ to provide a completely non-invasive, specific measure of cartilage PG content in 
a clinically feasible time remains. Further studies on the specificity and sensitivity of the technique are 
required as well the development and implementation of standardised pulse sequences. These 
challenges appear to be surmountable in the short to medium term and, encouragingly, should be 
achievable at current clinically available magnet field strengths. 
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With recent opinion suggesting that OA may initiate in the synovium, ligaments, tendons, menisci and 
other interrelated joint structures,[100, 101] the search for imaging biomarkers in these areas may 
represent an alternative approach to the diagnosis of early OA. Through this approach it may also be 
possible to obtain important information about the phenotypic expression of OA in general. The study 
by Tan et al[92] has shown that the early involvement of the collateral ligaments in hand OA can be 
observed using well developed MRI protocols and currently available equipment. The opportunity 
exists to translate this approach to other diarthrodial joints including the knee, although full joint 
coverage at sufficiently high resolution will be more challenging for larger joints. UTE sequences may 
also be beneficial for the purpose of delineating structures with very short T2 relaxation times. 
Closely related to the search for biomarkers of osteoarthritis, is the desire to infer the mechanical 
properties of cartilage using quantitative MRI. This would be of benefit to biotribological studies of 
articulating joints, allowing the effects of mechanical loading to be studied during in vitro wear 
simulations using dynamic MR sequences. The Finnish group at Kuopio/Oulu have contributed the 
majority of the research in this area and have developed a finite element model of cartilage based on 
its microscopic composition. Such models will benefit from input of the whole range of quantitative MR 
parameters discussed here. Much of the microscopic structure and composition of cartilage can be 
elucidated using MRI: collagen fibril orientation, PG and fluid content, however the depth-wise 
variation in collagen content is not yet quantifiable using MRI, and must be obtained using polarised 
light microscopy (PLM) or similar techniques. 
 
Conclusions 
Functional assessment of cartilage and other musculoskeletal tissues is possible through application 
of a number of quantitative MRI techniques. MR techniques exist that are sensitive to different 
aspects of the micro-anatomical structure of cartilage, including tissue hydration, glycosaminoglycan 
(GAG) content and the architecture of the cartilage collagen network. 
Quantitative assessment of cartilage GAG content represents perhaps the best opportunity to identify 
cartilage degradation at its earliest point and there are several MR techniques suitable for this 
purpose. T1ρ measurement may prove to be the most clinically feasible if the sensitivity and specificity 
of the parameter for cartilage GAG content can be established. Both dGEMRIC and sodium MRI offer 
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highly specific measurement of GAG content through quantification of fixed charge density, though 
their clinical implementation may be limited due to the invasiveness of the technique in the case of 
dGEMRIC and hardware dependency in the case of sodium MRI. Further development of emerging 
CEST-MR methods may allow for direct GAG quantification using the gagCEST technique. 
Quantitative relaxometry of cartilage offers a less specific assessment of cartilage with native T1 and 
T2 values as well as magnetisation transfer interactions dependent upon a variety of factors not 
limited to water content and mobility, GAG content and collagen fibril orientation. Further 
understanding of the macromolecular processes and interactions that determine tissue relaxation 
times may allow these phenomenological parameters to be incorporated into computational models 
able to predict the biomechanical properties of cartilage. Translating MRI parameters into specific 
mechanical properties of musculoskeletal tissues represents a significant challenge, but the potential 
benefits to areas of regenerative medicine and biomedical engineering of a means of non-invasive, 
quantitative assessment are clear. 
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Figure Legends 
 
Figure 1 a) Macromolecular composition of cartilage. The collagen fibril network provides the 
structural framework for cartilage and confers resistance to shear and tensile forces. 
Proteoglycans are embedded within the collagen network and consist of a central protein core 
and covalently attached negatively-charged glycosaminoglycan (GAG) side-chains. The 
negatively-charged GAGs increase the local concentration of cationic species such as Na
+
 and 
help to maintain fluid within the tissue, bestowing stiffness and resistance to compressive 
forces. b) In proteoglycan depleted cartilage, the loss of negatively-charged GAGs and 
corresponding reduction in mobile cation concentration diminish the ability of the cartilage 
macromolecular matrix to constrain fluid, reducing its capacity to withstand compression. 
 
 
Figure 2 Conventional parameter-weighted magnetic resonance images of a cadaveric knee 
joint. a) 2-D coronal intermediate-weighted spin-echo image used to assess gross joint 
alignment, collateral ligaments, medial and lateral menisci as well as cartilage morphology and 
presence or absence of sub-chondral cysts. b) 3-D T2
*
-weighted gradient echo image with 
selective water excitation; a 3-D acquisition which allows the cartilage thickness and volume 
to be measured as well as providing information about bone attrition and osteophyte 
formation. 
 
Figure 3 Quantitative MR parameter mapping. A pixel-by-pixel map of a single MR property is 
displayed on top of an anatomical image, showing the variation of that particular parameter in 
a region of interest (ROI). This particular image shows the variation in T2 relaxation time in the 
femoral articular cartilage and patellar cartilage of the knee joint. 
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
20 
 
Figure 4 Distribution of gadolinium diethylenetriamine pentaacetic acid ([Gd(DTPA)
2-
]) in a) 
healthy and b) glycosaminoglycan (GAG) depleted cartilage extracellular matrix. The local 
concentration of the administered gadolinium contrast agent is inversely proportional to 
cartilage GAG content due to the electrostatic repulsion between negatively-charged GAGs 
and the negatively-charged contrast agent. Water proton T1 relaxation times are reduced in the 
vicinity of the paramagnetic contrast agent and can therefore be used to measure GAG 
concentration. 
 
Figure 5 Distribution of sodium ions (Na
+
) in a) healthy and b) glycosaminoglycan (GAG) 
depleted cartilage extracellular matrix. The negative fixed charge density of 
glycosaminoglycan is balanced by cationic sodium ions. GAG depleted regions have lower 
negative fixed charge density and therefore fewer sodium ions. MRI techniques can measure 
the sodium concentration, allowing the fixed charge density and GAG concentration to be 
calculated.  
 
Figure 6 Saturation transfer effects between protons in the free and bound water pools and 
exchangeable protons of solute molecules. a) In magnetisation transfer (MT), an off-resonance 
radio-frequency (RF) pulse saturates the broad proton resonance of low mobility bound water 
molecules. Proton exchange between bound water molecules and the free water pool results 
in saturation transfer to the free water pool and a detectable reduction in the signal intensity of 
the free water resonance (b). The magnetisation transfer ratio is defined as MTR = 1 – SMT / S0, 
where S0 is the signal intensity recorded without a preparatory saturation pulse and SMT
 
is the 
signal intensity observed with the inclusion of a preparatory saturation pulse.  c) In the 
chemical exchange saturation transfer (CEST) technique solute protons are selectively 
saturated using by an RF pulse. Chemical exchange of the solute protons with water protons 
again results in saturation transfer to the free water pool and a measurable reduction in water 
proton signal intensity. 
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Figure 7 Molecular structure of one disaccharide unit of chondroitin-4-sulfate, one of the 
constituent glycosaminoglycans of proteoglycan. Exchangeable protons that contribute to the 
chemical exchange saturation transfer (CEST) effects seen using the gagCEST technique are 
highlighted.  
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